Additionally, Metrnl, which is arecently discovered secreted protein, is promising as a new biomarker for CHD.Furthermore, the roles of potential biomarkers of CVD, such as DCN and myonectin,in predicting cardiovascular disease and poor prognosis need to be furtherexplored. This evidence concerns the gene DCN and coronary artery disorder.